RT info:eu-repo/semantics/article
T1 Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
A1 González Valdivieso, Juan
A1 Girotti ., Alessandra
A1 Schneider, Jose
A1 Arias Vallejo, Francisco Javier
K1 Cancer
K1 Nanomedicine
K1 Chemotherapy
K1 Drug delivery
K1 Nanodrugs
AB Cancer has reached pandemic dimensions in the whole world. Although current medicine offers multiple treatment options against cancer, novel therapeutic strategies are needed due to the low specificity of chemotherapeutic drugs, undesired side effects and the presence of different incurable types of cancer. Among these new strategies, nanomedicine arises as an encouraging approach towards personalized medicine with high potential for present and future cancer patients. Therefore, nanomedicine aims to develop novel tools with wide potential in cancer treatment, imaging or even theranostic purposes. Even though numerous preclinical studies have been published with successful preliminary results, promising nanosystems have to face multiple obstacles before adoption in clinical practice as safe options for patients with cancer. In this MiniReview, we provide a short overview on the latest advances in current nanomedicine approaches, challenges and promising strategies towards more accurate cancer treatment.
PB Elsevier
SN 0378-5173
YR 2021
FD 2021
LK https://uvadoc.uva.es/handle/10324/73938
UL https://uvadoc.uva.es/handle/10324/73938
LA eng
NO International Journal of Pharmaceutics, April 2021, vol. 599, 120438
NO Producción Científica
DS UVaDOC
RD 22-ene-2025